New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
D000804:Angiotensin II / Q000037:antagonists & inhibitors* / Q000138:chemical synthesis / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000494:pharmacology; D002699:Chlorambucil / Q000138:chemical synthesis* / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007532:Isoleucine / Q000138:chemical synthesis* / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship; D014599:Uterus / Q000187:drug effects; D014633:Valine / Q000138:chemical synthesis* / Q000494:pharmacology
D007532:Isoleucine; D000804:Angiotensin II; D002699:Chlorambucil; D006632:Histamine; D014633:Valine; D001920:Bradykinin; D004837:Epinephrine